Press Archives

Cannabis and hemp labs need high quality, end-to-end testing and analysis solutions to keep up with growing demand and regulations. PerkinElmer is teaming up with Emerald Scientific to help.

With PerkinElmer’s spectrometer on board, the all-women research voyage is on the mission of identifying and documenting microplastics during the sails.

Duchenne Muscular Dystrophy is a rare genetic disorder and the most prevalent type of muscular dystrophy. The FDA has approved PerkinElmer’s GSP^® Neonatal Creatine Kinase-MM (CK-MM) kit for DMD screening.

ESPGHAN recently updated guidelines for the diagnosis of Celiac disease, which are expected to be more widespread and easy for both patients and gastroenterologists.

Have you ever thought AI can help diagnose genetic disorders? A Boston company is helping clinicians narrow down a patient’s diagnosis out of thousands of disorders with facial recognition technology.

AI and machine learning can help pharmas repurpose failed clinical trial data to drive new breakthroughs and treatments. David Wang, Masha Hoffey and Dr. Simone Sharma discuss key considerations and best practices.

PerkinElmer's new MuviCyte live-cell imaging system helps researcher study cell behavior and function in new ways. Karin Boettcher weighs in on the importance of controlling environmental parameters with advanced innovation.

PerkinElmer offers high-throughput platforms for electrophoresis-based biomolecule separation, sizing, and quantitation.

Mycotoxin testing for grains is a key step in securing global food safety. PerkinElmer’s Mark McBeath discusses best practices and innovative solutions for analysis from strips to LC-MS/MS.

PerkinElmer Genomics will begin processing about 2,500 samples with the Vanadis non-invasive prenatal testing (NIPT) system in Pittsburgh and Kuala Lumpur.

In this article PerkinElmer’s Toby Astill and Aaron Hineman weigh in on the use of ICP-MS to tackle heavy metals testing in cannabis.

Rice is a mega-staple for global consumers and testing for rice quality is key. The newPaddyCheck testing platform speeds sample throughput, increases accuracy and allows for grain testing at the paddy stage whether in-field or in a lab.

PerkinElmer launched the PG-Seq Rapid Non-Invasive Preimplantation Genetic Testing Kit, which tests spent embryo culture media for chromosomal abnormalities during in vitro treatment.

PerkinElmer is exploring the use of deep learning methods to improve analysis of image data from high content screening—in some cases, solving problems that conventional algorithms can’t.

Food safety is paramount. In this byline, PerkinElmer’s Greg Sears discusses advances in testing and analysis for everything from heavy metals, pesticides and mycotoxins, to foodborne pathogens and antibiotics.

A new clinical study further validates PerkinElmer’s Vanadis non-invasive prenatal testing (NIPT) system, which uses fully-automated imaging instead of DNA sequencing or PCR amplification.

Dr. Madhuri Hegde of PerkinElmer Genomics talks about the critical role that genetic counseling plays in consumer-initiated DNA testing today.

In this video, Justin Waldron of EUROIMMUN provides an overview of the high-capacity EUROLabWorkstation at AACC 2019.

To battle food fraud, PerkinElmer’s Greg Sears and Stefan Tordenmalm explain how robust analytical and informatics solutions can detect and analyze adulterants throughout the supply chain.

Beachcombing in Spain drew PerkinElmer’s Ian Robertson into not only his main field of research but an endeavor that fuels debate on microplastics in bottled water.

Linh Hoang, PerkinElmer’s vice president of Reproductive Health, spoke with Bloomberg about molecular testing options available right now for screening newborns with SMA (spinal muscular atrophy).

Angelo Filosa of PerkinElmer OneSource explains how working with a relocation service provider can minimize disruptions to daily operations and ensure a successful lab move.

In this article, Dr. Marc Pollmann, EUROIMMUN biologist, outlines the factors that play into accurate identification, diagnosis and treatment of tickborne illnesses like Lyme disease.

PerkinElmer and FDNA have partnered to offer genomic services paired with next-generation phenotyping technologies. The new service combines PerkinElmer Genomics' Ordered Data Interpretation Network (ODIN) software platform with FDNA's Face2Gene facial analysis technology.

Today more than half of all US citizens -- and people from 44 other countries -- have access to legal medical cannabis. As this market continues to grow and becomes more mainstream, calls for regulation and the need for the cannabis industry to ensure patient and consumer safety will similarly increase.

Prahlad Singh, president and chief operating officer, shares an update on PerkinElmer's new office facility in Singapore and growing customer base throughout Southeast Asia.

PerkinElmer is supporting the launch of Parent Project Muscular Dystrophy's (PPMD) pilot program to screen newborns in New York state for Duchenne—one of the most common forms of muscular dystrophy.

Researchers are looking for ways to more easily and effectively access, analyze and spotlight scientific data that is growing in volume and complexity and often dispersed across hard-to-access silos.

PerkinElmer will integrate its big data technology and content into Accenture's cloud-based platform, designed to drive wider efforts in drug discovery and research.

PerkinElmer was recognized as a leader in the scientific instrument industry at the 13th China Scientific Instrument Annual Conference.

As part of our mission to innovate for a healthier world, PerkinElmer is providing laboratories with the analytical tools needed to ensure safe, high-quality and compliant cannabis products.

PerkinElmer will relocate its Canadian demonstration lab to Velocity Garage, giving entrepreneurs and scientists access to the company's lab instruments, software and experts.

As with many sectors of the food market, the dairy and dairy product industry is evolving. A growing world population, rising standards of living in developing nations and increases in product variety are reshaping the industry.

Emerald Scientific awarded the "Emerald Test" badges to PerkinElmer, affirming our instruments' ability to accurately detect pesticides, heavy metals, residual solvents, terpenes and potency in cannabis.

Optimization of experimental assay design is crucial for the overall success of any drug discovery initiative.

Dr. Linh Hoang, M.D., Ph.D., vice president of Reproductive Health, outlines why early detection of preeclamspia provides a valuable window of opportunity for vigilance and intervention.

In this "Bold Types" feature, CFO Jamey Mock highlights some of the ways PerkinElmer will look to drive future growth.

Drug development is facing change from both technological pressures, including the use of AI and machine learning, and new regulations, which are transforming the way electronic records are created and stored for clinical trials.

For cannabis and hemp analysis, the high sensitivity of the QSight 400 Series supports laboratories in meeting state and federal regulations, including California and Canada.

Monitoring of residues in food substances is critical to ensuring no products are sold that contain dangerous levels of pesticides. Testing for even the smallest amounts of contaminants requires innovative lab equipment to guarantee products meet strict regulatory requirements.

The test, designed for noninvasive prenatal screening for trisomies 21, 18, and 13, with Y chromosome testing as an optional marker, has been validated in an external clinical study in France.

David Wang, general manager of Informatics, explains how scientists can harness valuable information quickly to achieve better, faster outcomes—and expedite the drug discovery process—by taking "the 3Vs" into account.

AI comes in many forms, but machine learning and natural language processing are two which are helping drug discovery scientists find new drug candidates.

EUROIMMUN's Dr. Konstanze Stiba discusses the challenges associated with developing a diagnostic for "Disease X," which represents newly emerging pathogens that present a significant public health risk - with the potential for an international epidemic.

Sanofi Genzyme and PerkinElmer Genomics have launched a free genetic testing program that aims to spot certain undiagnosed lysosomal storage disorders, while raising awareness of the group of rare diseases whose symptoms may initially be ascribed to more common ailments.

Jamey Mock talks about the first 120 days in his role as PerkinElmer CFO.

PerkinElmer scientists are testing cannabis for pesticide and mycotoxin levels using an LC-MS/MS method.

Whole genome and whole exome sequencing will be offered through its laboratories in the U.S., India, and China.

The Avio is designed for analytical labs running high throughput multi-elemental inorganic analyses for a variety of sample matrices.

PerkinElmer’s DELFIA Xpress PIGF 1-2-3 assay has been successfully utilized for identifying and monitoring women who are at risk of preeclampsia as part of Fetal Medicine Foundation’s ASPRE study.

China is making progress in its fight against pollution, though it still has a long way to go.

The deal will expand PerkinElmer's reach into autoimmune and allergy diagnostic markets.

PerkinElmer’s TR-FRET-based homogeneous assays use metal chelates as donor fluorophore.

PerkinElmer's Torion T-9 portable GC/MS brings new meaning to portability.

A new immunoassay developed by PerkinElmer has been demonstrated to successfully screen for Duchenne muscular dystrophy (DMD) – a fatal X-chromosome recessive disorder, affecting 1 in 5000 male births world-wide.

ViaCord helped fund a small, but promising study that suggests stem cells from a child’s own cord blood may offer an effective treatment for autism symptoms.

The endothelial cells that line our blood vessels play an important role in maintaining and regulating blood flow, contributing to the natural process called haemostasis. PerkinElmer Opera Phenix^™ system highlighted.

Like many chemists of a certain age, Derek Lowe remembers the exact moment when he learned about the chemical-structure-drawing program we now call ChemDraw.

Technologies such as PerkinElmer’s Opal platform and its multispectral imaging and analysis software allow researchers to multiplex immunology markers in a single assay on a single slide.

In a research first, Tufts scientists have witnessed atoms of one chemical element morph into another.

PerkinElmer, a maker of high-tech equipment used in the pharmaceutical industry, is joining Albany Molecular Research Inc. in a new, multimillion-dollar drug development hub soon to open on the Buffalo Niagara Medical Campus.

To minimize complexity, researchers often study cellular proteins or nucleic acids in isolation.

PerkinElmer of Shelton has received an Aquarion Environmental Champion Award. PerkinElmer company was recognized for its environmental efforts as well as for encouraging employees to participate voluntarily internal and external environmental projects.

PerkinElmer #940 on Fortune 1000.

Pharmaceutical and biotechnology companies are facing a gigantic increase in data — not just in volume, but in complexity.

Kinase assays that are compatible with high-throughput screening techniques are essential.

The goal of scientists is to partake in a breakthrough discovery leading to a solution that makes the world a better place.

For over 60 years, PerkinElmer has been providing unmatched versatility and sensitivity in radiometric detection. The new liquid scintillation counters are the most versatile, sensitive, and comprehensive LSCs on the market.

A report by the E.U. Committee on the Environment, Public Health and Food Safety identifies olive oil as being among the products most prone to food fraud.

Instrument firm executives at the Pittsburgh Conference on Analytical Chemistry & Applied Spectroscopy (Pittcon) this week said they want to see last year’s healthy sales pace continue into 2015.

PerkinElmer (Massachussetts, USA) has announced that they will collaborate with Waters Corporation (Massachussetts, USA) to standardize PerkinElmer liquid chromatography (LC) and gas chromatography (GC) instrumention.

Lab solutions provider PerkinElmer Inc. announced its collaboration with Johnson & Johnson Innovation to equip its JLABS @South San Francisco (JLABS @SSF) life science incubator with instruments and lab services to address the research needs of resident startups.

PerkinElmer Inc., a global leader focused on improving the health and safety of people and the environment, has announced the launch of its Adulterant Screen software.

Lab automation systems are used in R&D laboratories for a wide range of operational applications and purposes.

Operating in over 150 countries, PerkinElmer is one of the global companies listed on the S&P 500 and the Russell 3000 Indices.

An interview with Morey Kraus, Chief Scientific Officer of the Diagnostics division of PerkinElmer, and Kypros Nicolaides, Professor of Fetal Medicine, King's College, London, UK.

Scientific instruments maker PerkinElmer Inc on Thursday reported better-than-expected fourth quarter revenue and profit, helped by strong demand for its newborn screening tests in developing markets.

This new facility provides a comprehensive offering of lab services to hospitals and patients in China, supporting the prevention of birth defects in newborns and infectious disease in adults.

Food fraud is defined by the United Kingdom’s Food Standard Agency as date tampering or selling goods past their use-by date, packing and selling products with an unknown origin, deliberately mislabeling food like farmed salmon as being wild, or using stolen or poached animal meat.

Severe Combined Immunodeficiency (SCID) is a group of disorders caused by defects in genes involved in the development and function of T-cells and other infection-fighting immune cells.

During biosimilar development, it is necessary to demonstrate that the physicochemical properties, efficacy, and safety (e.g., immunogenicity) of the biosimilar are similar to those of the targeted branded biologic.

Robert Roe investigates cloud and SaaS deployment models and the inherent flexibility and scalability they provide to users.

US-based PerkinElmer, Inc. (NYSE: PKI) has completed its acquisition of Sweden-based analytical instruments supplier Perten Instruments Group AB. The deal is worth around USD 266m. Perten supplies instruments for quality control of food, grain, flour and feed.

OncoSec Medical Inc, San Diego, a company developing DNA-based intratumoral cancer immunotherapies, recently announced a collaboration with PerkinElmer Inc and the University of California, Los Angeles (UCLA), to help researchers develop biomarker tests for evaluating a patient’s immune response to cancer.

PerkinElmer has acquired Perten Instruments for $266m to ‘significantly expand’ its presence in the food testing.

PerkinElmer Inc. (PKI) on Thursday reported third-quarter profit of $42.3 million. The results met Wall Street expectations. The average estimate of analysts surveyed by Zacks Investment Research was also for earnings of 57 cents per share.

Perkin Elmer has unveiled its Solaris quantitative optical molecular imaging system for use in small and large animal studies. The Solaris system can bridge molecular imaging research techniques to support potential clinical outcomes.

After a generation of outsourcing services to lower-cost providers, smart companies now realize that they need to reassess this strategy. Outsourcing did lower costs in a time of need, but it came at a high price.

Technology and humans have a two-way action/reaction relationship. Given the concerns over the quality of the air we breathe, one company has developed a small device that can measure local conditions.

PerkinElmer announced an agreement with Sofie Biosciences to commercialize the latter's preclinical PET, 3D CT, and X-ray systems. The partnership will be focusing on areas of research in pharmacology, oncology, immunology, cardiology and neurobiology.

Advocates for the Preeclampsia Foundation, a non-profit organization dedicated to reducing illness and death due to preeclampsia, will be participating in and raising money for the Foundation’s annual The Promise Walk for Preeclampsia™.

26 projects were presented in the science fair, and early this week a panel of judges - from teachers to engineers - came to SIS to look at the students' work.

PerkinElmer Inc. announces the launch of the NexION® 350 Inductively Coupled Plasma Mass Spectrometer (ICP-MS), its atomic spectroscopy product and Syngistix™ for ICP-MS Software, its next generation atomic spectroscopy software platform.

Scientific instruments maker PerkinElmer Inc. reported a higher-than-expected quarterly profit on Thursday, helped by increased demand for its medical diagnostics products and continued double-digit growth in China.

The unique properties of engineered nanoparticles (ENPs) have created intense interest in their environmental behavior. It’s crucial to understand their impact on the growing mechanism of crops used for human consumption.

The Lamina scanner is a high throughput imaging system designed to help research pathologists to more easily study protein expression and the relationships between disease markers in formalin-fixed, paraffin-embedded (FFPE) tissue sections.

Dr. Victor Weeden, GWU Forensics Department are among the first to use mass spectrometry, a highly sensitive technology, that accurately detects trace levels of illicit substances,  staying one step ahead of drug makers and criminals.

There is no other food quite like olive oil. There is also, apparently, no better motivator throughout history than the chance to make a quick buck.

PerkinElmer announced that it will release a cloud-based informatics platform that will focus on operational efficiency for collaborative R&D activities.

Good Start Genetics^®, Inc. announced a strategic agreement with PerkinElmer, Inc. to expand access to GoodStart Select^™ genetic carrier screening tests beyond the in vitro fertilization (IVF) setting to the broader women's health community.

PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, announced the launch of the Lamina multilabel slide scanner at the USCAP 2014 Annual Meeting.

A wireless cassette-sized flat panel detector component has been developed for digital radiography (DR) applications. The detector makes a streamlined transition from film to digital, and provides a lower radiation dose.

Danielle, 37, and her husband Akber, 38, from Pakistan, are using their experience to help thousands of other children avoid their little girl’s fate.

Cord blood banking involves collecting and preserving cord stem cells, which are extracted from the umbilical cord and placenta. They can also be extracted and preserved for potential future medical use.

Based on nearly two decades of clinical medicine, there’s no denying the incredible value of cord blood stem cells in treating nearly 80 life threatening diseases of the blood.

Due to economically motivated adulteration (EMA) and mislabeling, it is difficult to predict the exact nature of potential threats, so many in the food industry are looking to detection techniques that help detect “unknown-unknowns.”

Scientific instruments maker PerkinElmer Inc on Thursday forecast full-year earnings in line with current Wall Street estimates and its CEO sees a rosier 2014 after a year filled with uncertainty in  the markets it serves.

One of the key characteristics of whisky enjoyment is the aroma from the spirit with a recently designed copita (a tulip-shaped sherry glass), having been developed to maximize this experience.

Label-free technology has been demonstrated to be a robust, highly sensitive, automatable tool used to measure live, native cells in real time.

Whether you employ analytical instrumentation for quality or food safety or both, the type of analytical instrumentation and testing will vary based on where it’s employed in the food process.

PerkinElmer has introduced the AxION iQT GC-MS-MS system which has the identification capabilities of a triple quadruple in one instrument, according to the company.

Whole-animal imaging enables researchers to noninvasively identify a disease and its location within an animal subject, and to monitor disease development over time.

Five employees and one customer of PerkinElmer France teamed up to participate in a 24 h relay bicycle race near Tours (France) in support of cancer research.

Dairy processors are taking a hardline to try to eradicate" adulterants, such as urea and melamine, from milk powder, PerkinElmer has claimed following the launch of its new DairyGuard milk powder analyzer.

The PerkinElmer Informatics 2013 User Group Meeting kicked off at 9:30am EST in Waltham, Mass., with the launch of PKI Informatics' newest electronic laboratory notebook version, E-Notebook 2014.

In 1970, the United States government established the Environmental Protection Agency (EPA) in response to growing public demand for a cleaner environment.

The scientific and regulatory communities have long been aware of the potential for migration of vapors from contaminated subsurface areas into buildings.

PerkinElmer is expanding its Center for Personalized Health Innovation in Hopkinton by more than 50 percent and upping the headcount there, saying it hopes to foster more collaboration with area biotech, pharmaceutical and academic institutions.

Economic adulteration and counterfeiting of global food and consumer products are estimated to cost the industry $10 to $15 billion per year, according to a 2010 A.T. Kearney study.

In 1905, the U.S. Pharmacopeial Convention, the nonprofit standards-setting organization known as USP, introduced a method to check for heavy metals in U.S. pharmaceuticals.

A number of scandals has left consumers nervous about the quality of what they eat and spurred Beijing to take the matter much more seriously.